The invention relates to oligonucleotides acting predominantly by a sequence independent mode of action for the treatment of inflammatory diseases. The invention also relates to oligonucleotides and their use as therapeutic agents, and more particularly for their use in methods of treatment and formulations for the treatment of inflammatory diseases.
申请公布号
WO2007022642(A3)
申请公布日期
2007.11.08
申请号
WO2006CA01409
申请日期
2006.08.25
申请人
REPLICOR INC.;VAILLANT, ANDREW;JUTEAU, JEAN-MARC;BAZINET, MICHEL
发明人
VAILLANT, ANDREW;JUTEAU, JEAN-MARC;BAZINET, MICHEL
